Article
Clinical significance of the p53 pathway and associated gene therapy in non-small cell lung cancers.
Future oncology (London, England) - 1 Feb 2007
Huang Cheng-long, Yokomise Hiroyasu, Miyatake Akira
Abstract excerpt
Many molecules, including several regulators and various target genes, are involved in the biological functions of p53, thus making the p53 pathway rather complicated. However, recent clinical studies have demonstrated that most human cancers have an abnormality in some of the molecules associated with the p53 pathway. Most non-small cell lung cancers (NSCLCs) have either mutations of p53, a reduced p14 alternate...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
